These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
49. Therapeutic options in treatment of advanced carcinoma of the prostate. Venner PM Semin Oncol; 1990 Dec; 17(6 Suppl 9):73-7. PubMed ID: 2259929 [TBL] [Abstract][Full Text] [Related]
50. How is androgen-dependent metastatic prostate cancer best treated? Robson M; Dawson N Hematol Oncol Clin North Am; 1996 Jun; 10(3):727-47. PubMed ID: 8773508 [TBL] [Abstract][Full Text] [Related]
51. [Castration in the treatment of locally advanced or metastatic prostate cancer]. Mongiat-Artus P Rev Prat; 2013 Apr; 63(4):509-10. PubMed ID: 23682480 [No Abstract] [Full Text] [Related]
52. Metastatic large-cell neuroendocrine prostate carcinoma: successful treatment with androgen deprivation therapy. Azad AA; Jones EC; Chi KN Clin Genitourin Cancer; 2014 Aug; 12(4):e151-3. PubMed ID: 24787970 [No Abstract] [Full Text] [Related]
53. A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for carcinoma of the prostate. Smith JA J Urol; 1994 Jul; 152(1):132-4. PubMed ID: 8201642 [TBL] [Abstract][Full Text] [Related]
54. Androgen deprivation as primary treatment for early prostate cancer: should we "just do something"? Talcott JA J Natl Cancer Inst; 2002 Mar; 94(6):407-9. PubMed ID: 11904307 [No Abstract] [Full Text] [Related]
55. Ureteral obstruction from prostatic carcinoma: response to endocrine and radiation therapy. Michigan S; Catalona WJ J Urol; 1977 Nov; 118(5):733-8. PubMed ID: 916091 [TBL] [Abstract][Full Text] [Related]
56. [Natural history of metastasic prostate cancer treated with androgen deprivation therapy and secondary hormonal therapy efficiency]. Rodriguez García N; Luján Galán M; Pascual Mateo C; García Tello AM; Torres Zambrano GM; Berenguer Sánchez A Actas Urol Esp; 2007; 31(7):714-8. PubMed ID: 17902463 [TBL] [Abstract][Full Text] [Related]
57. Prostate cancer. Endocrine and cytotoxic therapy. Smith PH Recent Results Cancer Res; 1981; 78():154-72. PubMed ID: 7022593 [No Abstract] [Full Text] [Related]
58. Relationship between androgen receptor binding activity in human prostate cancer and clinical response to endocrine therapy. Benson RC; Gorman PA; O'Brien PC; Holicky EL; Veneziale CM Cancer; 1987 May; 59(9):1599-606. PubMed ID: 3828960 [TBL] [Abstract][Full Text] [Related]